Log in
Enquire now
‌

US Patent 7232437 Assessment of lesion transmurality

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
72324370
Patent Inventor Names
Robert H. Svenson0
Gregory G. Brucker0
Adam L. Berman0
Date of Patent
June 19, 2007
0
Patent Application Number
111339000
Date Filed
May 19, 2005
0
Patent Citations Received
‌
US Patent 12114911 System and method for ablating a tissue site by electroporation with real-time pulse monitoring
0
‌
US Patent 11957405 Methods of sterilization and treating infection using irreversible electroporation
0
‌
US Patent 11974800 Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
0
‌
US Patent 12059197 Blood-brain barrier disruption using reversible or irreversible electroporation
0
‌
US Patent 12076081 Systems and methods for optical interrogation of ablation lesions
0
‌
US Patent 12075980 Systems and methods for visualizing ablated tissue
0
‌
US Patent 12102376 System and method for increasing a target zone for electrical ablation
0
‌
US Patent 11655466 Methods of reducing adverse effects of non-thermal ablation
0
...
Patent Primary Examiner
‌
A. Farah
0
Patent abstract

A method and apparatus for treating a body tissue in situ (e.g., an atrial tissue of a heart to treat) atrial fibrillation include a lesion formation tool is positioned against the heart surface. The lesion formation tool includes a guide member having a tissue-opposing surface for placement against a heart surface. An ablation member is coupled to the guide member to move in a longitudinal path relative to the guide member. The ablation member has an ablation element for directing ablation energy in an emitting direction away from the tissue-opposing surface. The guide member may be flexible to adjust a shape of the guide member for the longitudinal path to approximate the desired ablation path while maintaining the tissue-opposing surface against the heart surface. In one embodiment, the ablation member includes at least one radiation-emitting member disposed to travel in the longitudinal pathway. Transmurality can be assessed to approximate a location of non-transmurality in a formed lesion.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7232437 Assessment of lesion transmurality

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.